Healthcare
fromwww.amny.com
12 hours agoOp-ed | To tackle affordability, we must have fair hospital pricing | amNewYork
Two out of three New Yorkers delayed healthcare due to costs, with hospital price inflation exceeding 100% since 2009.
Most people leave doctor visits with prescriptions, but still feel unsure—instructions make sense, but no one asks about their life. In contrast, when a provider knows your name, remembers your story, and explains care in a way that fits you, the experience feels different—and that difference matters.
In light of the systemic dismantling of America's public health agencies, these moves essentially create a shadow infrastructure to maintain some of what is being lost. While this is a promising development, it does nothing to stop a troubling trend that has been emerging for some time: The country is quickly becoming fragmented along partisan lines when it comes to public health.
The 340B program allows hospitals to buy outpatient drugs at steep discounts, with the purported purpose of helping them fund care for low-income and uninsured patients. The now-axed rebate model would have invited drugmakers to participate voluntarily in a rebate-based discount system. Basically, instead of the provider receiving a discount upfront at purchase, the 340B discount would be applied after purchase via rebate - and subject to tedious data submission requirements.